SEC Filings

10-K
ARRAY BIOPHARMA INC filed this Form 10-K on 08/11/2017
Entire Document
 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature
 
Title
 
Date
 
 
 
 
 
 
 
 
 
 
/s/ RON SQUARER
 
Chief Executive Officer
 
August 11, 2017
Ron Squarer
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/ JASON HADDOCK
 
Chief Financial Officer
 
August 11, 2017
Jason Haddock
 
(Principal Financial and Accounting Officer)
 
 
 
 
 
 
 
/s/ KYLE A. LEFKOFF
 
Chairman of the Board of Directors
 
August 11, 2017
Kyle A. Lefkoff
 
 
 
 
 
 
 
 
 
/s/ CHARLES M. BAUM
 
Director
 
August 11, 2017
Charles M. Baum, M.D., Ph.D.
 
 
 
 
 
 
 
 
 
/s/ GWEN A. FYFE
 
Director
 
August 11, 2017
Gwen A. Fyfe, M.D.
 
 
 
 
 
 
 
 
 
/s/ JOHN A. ORWIN
 
Director
 
August 11, 2017
John A. Orwin
 
 
 
 
 
 
 
 
 
/s/ SHALINI SHARP
 
Director
 
August 11, 2017
Shalini Sharp
 
 
 
 
 
 
 
 
 
/s/ GIL J. VAN LUNSEN
 
Director
 
August 11, 2017
Gil J. Van Lunsen
 
 
 
 
 
 
 
 
 

77